Sex-related dimorphic response of HIF-1α expression in myocardial ischemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 2, 2006, Pages

  Zampino, Manuela ^a   Yuzhakova, Milana ^a   Hansen, James ^a   McKinney, Ronald D ^a   Goldspink, Paul H ^a   Geenen, David L ^a   Buttrick, Peter M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Gene expression; Hypoxia inducible factor 1 ; Remodeling

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; FEMALE; GENE EXPRESSION; GENE TARGETING; HEART MUSCLE ISCHEMIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; STAINING; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ANIMALS; FEMALE; GENE EXPRESSION; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NITROIMIDAZOLES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEX CHARACTERISTICS; VENTRICULAR REMODELING;

EID: 33746826853     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00580.2005     Document Type: Article

References (53)

1. Albina JE, Mastrofrancesco B, Vessella JA, Louis CA, Henry WL Jr, and Reichner JS. HIF-1 expression in healing wounds: HIF-1α induction in primary inflammatory cells by TNF-α. Am J Physiol Cell Physiol 281: C1971-C1977, 2001.
2. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, and Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 28: 1176-1179, 1994.
3. Bergeron M, Yu A, Solway K, Semenza G, and Sharp F. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 11: 4159-4170, 1999.
4. Blau H and Banfi A. The well-tempered vessel. Nat Med 7: 532-534, 2001.
5. Brower G, Gardner J, and Janicki J. Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy. Mol Cell Biochem 251: 89-95, 2003.
6. Bruick RK and McKnight SL. Building better vasculature. Genes Dev 15: 2497-2502, 2001.
7. Cabral AM, Vasquez EC, Moyses MR, and Antonio A. Sex hormone modulation of ventricle hypertrophy in sinoaortic denervated rats. Hypertension 11: I93-I97, 1988.
8. Carmeliet P, Dor Y, Herbert J, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch C, Ratcliffe P, Moons L, Jain R, Collen D, Keshert E, and Keshet E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490, 1998.
9. Cavasin M, Tao Z, Menon S, and Yang X. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci 75: 2181-2192, 2004.
10. Cioffi C, Liu X, Kosinski P, Garay M, and Bowen B. Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem Biophys Res Commun 303: 947-953, 2003.
11. Crabbe DL, Dipla K, Ambati S, Zafeiridis A, Gaughan JP, Houser SR, and Margulies KB. Gender differences in post infarction hypertrophy in end-stage failing hearts. J Am Coll Cardiol 41: 300-306, 2003.
12. Depre C, Kim SJ, John AS, Huang Y, Rimoldi OE, Pepper JR, Dreyfus GD, Gaussin V, Pennell DJ, Vatner DE, Camici PG, and Vatner SF. Program of cell survival underlying human and experimental hibernating myocardium. Circ Res 95: 433-440, 2004.
13. Epstein A, Gleadle J, McNeill L, Hewitson K, O'Rourke J, Mole D, Mukherji M, Metzen E, Wilson M, Dhanda A, Tian Y, Masson N, Hamilton D, Jaakkola P, Barstead R, Hodgkin J, Maxwell P, Pugh C, Schofield C, and Ratcliffe P. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54, 2001.
14. Fischer GM and Swain ML. Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats. Am J Physiol Heart Circ Physiol 232: H617-H621, 1977.
15. Fuster V, Badimon L, Badimon J, and Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326: 242-250, 1992.
16. Fuster V, Badimon L, Badimon J, and Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 326: 310-318, 1992.
17. Geenen D, Malhotra A, Liang D, and Scheuer J. Ventricular function and contractile proteins in the infarcted overloaded rat heart. Cardiovasc Res 25: 330-336, 1991.
18. Goldspink PH, Montgomery DE, Walker LA, Urboniene D, McKinney RD, Geenen DL, Solaro RJ, and Buttrick PM. Protein kinase Cε overexpression alters myofilament properties and composition during the progression of heart failure. Circ Res 95: 424-432, 2004.
19. Gothie E, Richard DE, Berra E, Pages G, and Pouyssegur J. Identification of alternative spliced variants of human hypoxia-inducible factor-1α. J Biol Chem 275: 6922-6927, 2000.
20. Graham RM, Frazier DP, Thompson JW, Haliko S, Li H, Wasserlauf BJ, Spiga MG, Bishopric NH, and Webster KA. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. J Exp Biol 207: 3189-3200, 2004.
21. Huang Y, Hickey RP, Yeh JL, Liu D, Dadak A, Young LH, Johnson RS, and Giordano FJ. Cardiac myocyte-specific HIF-1α deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J 18: 1138-1140, 2004.
22. 2 sensing. Science 292: 464-468, 2001.
23. Jiang BH, Zheng JZ, Leung SW, Roe R, and Semenza GL. Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem 272: 19253-19260, 1997.
24. Jung F, Palmer LA, Zhou N, and Johns RA. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res 86: 319-325, 2000.
25. Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW, and Thistlethwaite PA. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol 46: 2116-2124, 2005.
26. Kim CH, Cho YS, Chun YS, Park JW, and Kim MS. Early expression of myocardial HIF-1α in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res 90: 25e-33, 2002.
27. Knowles HJ, Tian YM, Mole DR, and Harris AL. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1α, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases. Circ Res 95: 162-169, 2004.
28. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, and Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342: 626-633, 2000.
29. Levy D, Garrison R, Savage D, Kannel W, and Castelli W. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566, 1990.
30. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, and Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol Heart Circ Physiol 270: H1803-H1811, 1996.
31. Li J, Hampton T, Morgan JP, and Simons M. Stretch-induced VEGF expression in the heart. J Clin Invest 100: 18-24, 1997.
32. Litwin S, Katz S, Litwin C, Morgan J, and Douglas P. Gender differences in postinfarction left ventricular remodeling. Cardiology 91: 173-183, 1999.
33. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JGN, and Semenza GL. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669, 2005.
34. Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M, Wykoff C, Pugh C, Maher E, and Ratcliffe P. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275, 1999.
35. McGill HC Jr, Anselmo VC, Buchanan JM, and Sheridan PJ. The heart is a target organ for androgen. Science 207: 775-777, 1980.
36. Nguyen S and Claycomb W. Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes. Biochem Biophys Res Commun 265: 382-386, 1999.
37. Nwogu JI, Geenen D, Bean M, Brenner MC, Huang X, and Buttrick PM. Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction. Circulation 104: 2216-2221, 2001.
38. Philipp S. Prolyl 4-hydroxylase inhibition induced HIF and improved cardiac function after myocardial infarction (Abstract). Circulation 106: II267, 2002.
39. Schofield C and Ratcliffe P. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343-354, 2004.
40. Semenza G. Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J Lab Clin Med 131: 207-214, 1998.
41. 2 homeostasis. Curr Opin Genet Dev 8: 588-594, 1998.
42. Semenza G, Roth P, Fang H, and Wang G. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269: 23757-23763, 1994.
43. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev 14: 1983-1991, 2000.
44. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88: 1474-1480, 2000.
45. 2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol 96: 1173-1177, 2004.
46. Semenza GL. Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest 106: 809-812, 2000.
47. Semenza GL, Agani F, Iyer N, Kotch L, Laughner E, Leung S, and Yu A. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann NY Acad Sci 874: 262-268, 1999.
48. Spyridopoulos I, Sullivan AB, Kearney M, Isner JM, and Losordo DW. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis: estradiol as a survival factor. Circulation 95: 1505-1514, 1997.
49. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DAH, Bauer C, Gassmann M, and Candinas D. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15: 2445-2453, 2001.
50. Tomanek R, Lund D, and Yue X. Hypoxic induction of myocardial vascularization during development. Adv Exp Med Biol 543: 139-149, 2003.
51. Wang GL and Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230-1237, 1995.
52. Wiener C, Booth G, and Semenza G. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 225: 485-488, 1996.
53. Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY, Kuriyama T, Cheng SH, Gregory RJ, and Jiang C. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93: 664-673, 2003.